Sign in
EC

EASTMAN CHEMICAL CO (EMN)·Q1 2025 Earnings Summary

Executive Summary

  • Q1 2025 delivered resilient results amid rising trade/tariff uncertainty: adjusted EPS of $1.91 (+19% y/y) on sales of $2.290B (–1% y/y); Adjusted EBIT rose to $311M with a 170 bps y/y margin uplift to 13.6% as price-cost held and Kingsport methanolysis ran at best-ever uptime .
  • Versus S&P Global consensus, EMN posted a slight EPS beat ($1.91 vs $1.89*) and a modest revenue miss ($2.290B vs $2.330B*), reflecting strong execution but softer top line in Fibers and EMEA weakness .
  • Guidance pivot: management withdrew full‑year EPS guidance (was $8.00–$8.75 set Jan 30) and moved to quarterly EPS, guiding Q2 adjusted EPS of $1.70–$1.90; 2025 OCF guided to ~$1.2B (from ~$1.3B), capex cut to ~$550M, and cost reduction target increased to ~$75M net of inflation .
  • Near-term stock reaction catalysts: tariff path and China/U.S. trade visibility, Renew revenue cadence (revised to $50–$75M due to tariffs), sequential demand into June, and execution on capex/cost-down plan; mgmt quantified a $30M Q2 tariff-related volume headwind and flagged unusual Q2 turnaround costs ($20M) .

What Went Well and What Went Wrong

  • What Went Well

    • “Best-ever quarter of uptime and production quantities at the Kingsport methanolysis facility,” supporting a 170 bps y/y adjusted EBIT margin improvement to 13.6% and y/y EPS growth in line with expectations .
    • Additives & Functional Products (AFP) and Chemical Intermediates (CI) posted revenue growth y/y on higher price and volume/mix; AM EBIT up on mix and cost discipline .
    • CEO: “Our first-quarter results, coupled with our bias for action, give me great confidence in our ability to deliver strong cash flow and resilient earnings going forward” .
  • What Went Wrong

    • Fibers sales fell 13% y/y (–12% volume mix) on continued acetate tow destocking; EBIT declined in Fibers as volume fell and tariffs add near-term pressure (Naia textiles, cellulose flake into China) .
    • Operating cash flow was an outflow of $167M (vs $16M outflow in Q1’24), driven by working capital builds ahead of a heavier Q2 shutdown season; cash/equivalents ended at $418M vs $837M at YE’24 .
    • Tariffs: management reduced FY Renew sales expectation to $50–$75M (from $75–$100M) and quantified ~$30M Q2 impact, primarily a volume pause rather than duty absorption; Q2 seasonal uplift expected to be more muted .

Financial Results

Headline results (chronological: Q3 2024 → Q4 2024 → Q1 2025)

MetricQ3 2024Q4 2024Q1 2025
Sales revenue ($USD Billions)$2.464 $2.245 $2.290
GAAP Diluted EPS ($)$1.53 $2.82 $1.57
Adjusted EPS ($)$2.26 $1.87 $1.91
EBIT ($USD Millions)$329 $349 $302
Adjusted EBIT ($USD Millions)$366 $305 $311

Notes: Adjusted EBIT margin rose 170 bps y/y in Q1 2025 to 13.6% .

Actual vs Wall Street consensus (S&P Global)

MetricQ1 2025 ActualQ1 2025 ConsensusSurprise
Sales revenue ($USD Billions)$2.290 $2.330*–$0.040
Adjusted EPS ($)$1.91 $1.8869*+$0.02

Values with asterisks retrieved from S&P Global.

Segment revenue (sales) by quarter ($USD Millions)

SegmentQ1 2024Q4 2024Q1 2025
Advanced Materials748 720 719
Additives & Functional Products704 696 733
Chemical Intermediates523 503 545
Fibers331 321 288
Other4 5 5
Total2,310 2,245 2,290

Y/Y: AM –4%, AFP +4%, CI +4%, Fibers –13%; sequentially vs Q4: Total +2%, with AFP +5% and CI +8% offset by Fibers –10% .

Segment adjusted EBIT and margins

SegmentQ1 2024 Adj EBIT ($M)Q1 2024 Margin %Q4 2024 Adj EBIT ($M)Q4 2024 Margin %Q1 2025 Adj EBIT ($M)Q1 2025 Margin %
Advanced Materials104 13.9% 107 14.9% 116 16.1%
Additives & Functional Products109 15.5% 128 18.4% 141 19.2%
Chemical Intermediates16 3.1% 20 4.0% 19 3.5%
Fibers117 35.3% 103 32.1% 88 30.6%
Total segments346 15.0% 358 16.0% 364 15.9%
Other (ex non-core)(72) (53) (53)
Total Co. Adj EBIT274 11.9% 305 13.6% 311 13.6%

Regional sales mix

RegionQ1 2024 ($M)Q1 2025 ($M)
United States & Canada9691,020
EMEA659610
Asia Pacific564539
Latin America118121
Total2,3102,290

KPIs and cash

  • Cash from operations: $(167)M in Q1 2025 (vs $(16)M in Q1 2024), driven by working capital build ahead of heavier Q2 maintenance; dividends paid $96M; capex $147M; cash/equivalents $418M; net debt $4.603B .
  • GAAP tax rate 28% in Q1; adjusted full-year ETR assumption 16% .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Adjusted EPSFY 2025$8.00–$8.75 (Jan 30) Withdrawn; moving to quarterly EPS; Q2 adj EPS $1.70–$1.90 Shift to quarterly; added Q2 range
Operating Cash FlowFY 2025≈$1.3B (Jan 30) ≈$1.2B Lowered
Capital ExpendituresFY 2025$700–$800M discussed (Q4 call) ≈$550M Reduced
Cost Reduction Target (net of inflation)FY 2025≈$50M (Q4 call) ≈$75M Raised
DividendOngoing$0.83/qtr (as of Dec’24)$0.83/qtr declared for Jul 8, 2025 Maintained

Additional Q2 color: ~$30M tariff-related impact (volume), and ~$(20)M sequential headwind from planned turnarounds; Q3 turnaround at similar levels, Q4 eases .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q3’24, Q4’24)Current Period (Q1’25)Trend
Circular/methanolysis operations & salesQ3: lower 2024 EBITDA vs plan; downtime then better uptime in Sept; 65–70% run rate periods; explained cost vs volume drivers . Q4: 85% DMT yield since fall turnaround; improving operations into 2025 .“Best-ever” uptime/production at Kingsport; on track for cost targets; expect ~$50M manufacturing-side EBITDA benefit in 2025; Renew revenue revised to $50–$75M due to tariffs .Operationally improving; demand timing pressured by tariffs.
Tariffs/trade & macroQ4: watching policy path; no major forecast embedded yet .~$30M Q2 tariff impact mainly from customers pausing orders (volume, not duty); muted seasonal Q2 uplift as customers cautious; China-exposed flows discussed by segment .Headwind intensified near-term.
Fibers destocking/contractsQ3: inventory management likely continues; France policy slowed contracts for EU project . Q4: 80% of tow volume contracted into 2026; 60–70% into 2027 .Q1 Fibers volume –12% y/y; destocking persisting; tariffs affect Naia textiles and flake JV; ~90% price under contract for 2025 .Near-term weaker volumes; pricing stable under contracts.
Capex/Longview DOEQ3: FID Longview Texas; DOE $375M + Texas incentives; learnings to lower cap cost . Q4: 2025 capex initially framed $700–$800M; DOE funds already flowing .Capex cut to ~$550M; engineering-first approach to avoid timeline impact; continued confidence in DOE funding .More disciplined cash posture.
Energy/raw material costsQ4: higher natural gas forward; Q1 AM margin pinch early-year; paraxylene decline helped Q4 .Still a factor; mgmt cites smaller puts/takes vs demand trajectory for Q2 .Mixed; manageable.
Demand in discretionary end-marketsQ3: auto/housing/consumer durables weak; innovation drives AM growth above markets . Q4: stable markets steady; discretionary still below 2019 .April orders similar to March; seasonal Q2 uplift expected to be less than typical; customer caution, potential June risk if trade not resolved .Stable to softer near-term until visibility improves.

Management Commentary

  • “Leveraging our innovation-driven growth model, we delivered a strong quarter in line with expectations... We recorded our best-ever quarter of uptime and production quantities at the Kingsport methanolysis facility…” — Mark Costa, CEO .
  • “We are... increasing our cost reduction target to approximately $75 million net of inflation and reducing capital expenditures to around $550 million... expect to generate strong operating cash flow of approximately $1.2 billion for full-year 2025... moving to quarterly adjusted earnings per share guidance. Q2 adjusted EPS is expected to be in the range of $1.70 to $1.90.” .
  • On tariffs: “The [Q2] impact... is an impact on volume as opposed to an impact on duty... customers... can, through this quarter, just not order... It’s a volume hit as opposed to a tariff hit.” .
  • On Renew revision: “Revision... from $75–$100M of revenue to $50–$75M... purely an end market estimation of the impact of tariffs... nothing to do with the engagement we’re seeing in the marketplace.” .

Q&A Highlights

  • Tariff impact quantified: ~$30M in Q2, largely from customer order pauses; exposure varies by segment (no CI exposure; manageable AFP exposure; AM exposure tied to performance films and specialty plastics supply chains); management working on localization and customer rerouting .
  • Demand cadence: Q2 typically sees strong seasonal uplift; this year uplift expected to be “more muted” amid trade uncertainty; April order book holding similar to March .
  • Fibers: continued destocking despite stable end-market consumption; contracts provide price stability with volume bands; tariffs affect Naia textiles and cellulose flake JV with CNTC .
  • Capex strategy and Longview: capex cut timed to engineering phase to preserve project timeline; DOE engagement remains supportive; capex mid-point cut from ~$750M to ~$550M for 2025 .
  • Turnarounds: ~$(20)M sequential headwind in Q2; similar impact in Q3; improvement in Q4 .

Estimates Context

  • Q1 2025 results vs S&P Global consensus: adjusted EPS $1.91 vs $1.8869* (beat by ~$0.02); revenue $2.290B vs $2.330B* (miss by ~$$0.04B). 15 EPS estimates, 11 revenue estimates informed the consensus .
  • Implications: Consensus may need to reflect (i) the quarterly EPS guidance framework (Q2 $1.70–$1.90), (ii) $75M cost-reduction plan and capex cut to $550M, (iii) tariff-volume headwind and muted seasonal uplift, and (iv) Renew revenue trimmed to $50–$75M near term .

Values with asterisks retrieved from S&P Global.

Key Takeaways for Investors

  • Execution remains solid: y/y EPS growth (+19% adjusted) and margin expansion in Q1 despite macro/tariff headwinds; AM and AFP continue to expand margins, aided by mix, commercial excellence, and methanolysis operations .
  • Near-term risk skew: Q2 tariff-driven order pauses ($30M) and heavier maintenance ($(20)M) temper seasonal uplift; watch June order trends and policy headlines for demand inflection .
  • Guidance reset favors cash discipline: capex cut to ~$550M and cost-down raised to ~$75M net of inflation underpin ~$1.2B OCF target; mgmt shifted to quarterly EPS guidance to reflect uncertainty .
  • Renew trajectory intact operationally but delayed commercially: best-ever Kingsport uptime; revenue cadence revised to $50–$75M on tariff-driven end-market constraints; potential rebound if tensions ease .
  • Segment positioning: AFP and CI benefiting from price-cost and volume tailwinds; Fibers pressured by destocking and China tariffs but supported by high contract coverage; AM levered to auto/interlayers mix and performance films localization .
  • Watchlist catalysts: trade policy evolution; Q2 order cadence into June; Renew PET ramp in 2H; DOE funding flow and Longview engineering milestones; natural gas/energy cost trajectory .